Last reviewed · How we verify
Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation
The aim of this study is to determine whether or not continuous combined oral contraceptive pills (COCP's) decrease the risk of recurrent endometrioma formation. The investigators' hypothesis is that patients who have endometriomas surgically removed and then are started on COCP's will have a decreased incidence of recurrent endometrioma formation. The investigators' research protocol is designed to show a statistically significant decreased incidence of endometrioma formation in the hopes that physicians will use COCP's in patients they have removed an endometrioma in who do not desire immediate fertility. Long term, the investigators hope to establish a standard of care that COCP's be used postoperatively in appropriate candidates to decrease the chance of recurrent endometrioma formation.
Details
| Lead sponsor | University of Oklahoma |
|---|---|
| Phase | NA |
| Status | WITHDRAWN |
| Start date | 2009-10 |
| Completion | 2011-10 |
Conditions
- Endometrioma
Interventions
- Norethindrone acetate and ethinyl estradiol tablets, USP
- ferrous fumarate (placebo) tablets
Primary outcomes
- To determine whether or not continuous combined oral contraceptive pills decrease the risk of recurrent endometrioma formation. — October 2011
Countries
United States